Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DAVE Dave	$191.39 -2.4%	$224.56	$30.20 ▼ $286.45	$2.62B	3.95	742,267 shs	1.01 million shs
NVDA NVIDIA	$180.77 +0.8%	$158.02	$86.62 ▼ $183.88	$4.38T	2.14	162.65 million shs	151.26 million shs
SMR NuScale Power	$44.79 -2.5%	$40.67	$6.88 ▼ $53.50	$13.06B	2.06	13.92 million shs	12.55 million shs
TMDX TransMedics Group	$116.05 -2.3%	$124.11	$55.00 ▼ $177.37	$4.05B	2.09	1.39 million shs	869,973 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DAVE Dave	-17.89%	-18.36%	-29.91%	+28.79%	+528.36%
NVDA NVIDIA	+0.65%	+0.08%	+13.38%	+52.85%	+72.11%
SMR NuScale Power	+1.79%	-8.98%	+24.79%	+171.65%	+465.15%
TMDX TransMedics Group	-5.52%	+10.31%	-5.09%	+27.39%	-23.89%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DAVE Dave	3.8501 of 5 stars	4.4	2.0	0.0	0.0	2.3	2.5	1.9
NVDA NVIDIA	4.6605 of 5 stars	2.5	5.0	1.7	3.0	3.9	2.5	1.9
SMR NuScale Power	1.7995 of 5 stars	2.1	3.0	0.0	0.0	2.6	2.5	0.6
TMDX TransMedics Group	2.6441 of 5 stars	2.4	2.0	0.0	0.0	3.2	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DAVE Dave	2.89	Moderate Buy	$253.83	32.63% Upside
NVDA NVIDIA	2.93	Moderate Buy	$183.75	1.65% Upside
SMR NuScale Power	2.27	Hold	$33.00	-26.32% Downside
TMDX TransMedics Group	2.78	Moderate Buy	$123.00	5.99% Upside

Current Analyst Ratings Breakdown

Latest TMDX, NVDA, DAVE, and SMR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/7/2025	DAVE Dave	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
8/7/2025	DAVE Dave	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Market Outperform ➝ Market Outperform	$260.00 ➝ $280.00
8/4/2025	DAVE Dave	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$290.00
8/1/2025	NVDA NVIDIA	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
8/1/2025	TMDX TransMedics Group	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$115.00 ➝ $123.00
7/30/2025	NVDA NVIDIA	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$170.00 ➝ $200.00
7/29/2025	DAVE Dave	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$239.00 ➝ $277.00
7/25/2025	SMR NuScale Power	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
7/25/2025	SMR NuScale Power	BNP Paribas Exane Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$41.00
7/16/2025	NVDA NVIDIA	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target		$185.00 ➝ $200.00
7/16/2025	NVDA NVIDIA	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target		$180.00 ➝ $220.00

(Data available from 8/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DAVE Dave	$347.10M	7.36	$4.90 per share	39.07	$14.01 per share	13.66
NVDA NVIDIA	$130.50B	33.80	$3.08 per share	58.68	$3.25 per share	55.62
SMR NuScale Power	$49.04M	259.74	$0.15 per share	307.51	$1.64 per share	27.31
TMDX TransMedics Group	$441.54M	8.96	$1.61 per share	72.20	$9.33 per share	12.44

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DAVE Dave	$57.87M	$3.78	50.63	65.77	N/A	12.74%	34.75%	21.09%	N/A
NVDA NVIDIA	$72.88B	$3.10	58.31	45.42	1.58	51.69%	105.09%	72.19%	8/27/2025 (Estimated)
SMR NuScale Power	-$136.62M	-$1.37	N/A	N/A	N/A	-273.36%	0.09%	0.07%	8/7/2025 (Estimated)
TMDX TransMedics Group	$35.46M	$1.93	60.13	81.15	N/A	13.49%	28.02%	8.64%	N/A

Latest TMDX, NVDA, DAVE, and SMR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/27/2025	Q2 2026	NVDA NVIDIA	$1.00	N/A	N/A	N/A	$45.65 billion	N/A
8/7/2025	Q2 2025	SMR NuScale Power	-$0.1199	-$0.13	-$0.0101	-$0.13	$10.49 million	N/A
7/30/2025	Q2 2025	TMDX TransMedics Group	$0.48	$0.92	+$0.44	$0.92	$146.64 million	$157.37 million
5/28/2025	Q1 2026	NVDA NVIDIA	$0.87	$0.81	-$0.06	$0.76	$43.09 billion	$44.06 billion
5/12/2025	Q1 2025	SMR NuScale Power	-$0.1694	-$0.11	+$0.0594	-$0.11	$1.46 million	$13.38 million
5/8/2025	Q1 2025	DAVE Dave	$0.82	$1.97	+$1.15	$1.97	N/A	N/A
5/8/2025	Q1 2025	TMDX TransMedics Group	$0.29	$0.70	+$0.41	$0.70	$123.39 million	$143.54 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DAVE Dave	N/A	N/A	N/A	N/A	N/A
NVDA NVIDIA	$0.04	0.02%	N/A	1.29%	1 Years
SMR NuScale Power	N/A	N/A	N/A	N/A	N/A
TMDX TransMedics Group	N/A	N/A	N/A	N/A	N/A

Latest TMDX, NVDA, DAVE, and SMR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/28/2025	NVDA NVIDIA	quarterly	$0.01	0.03%	6/11/2025	6/11/2025	7/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DAVE Dave	0.38	8.59	8.59
NVDA NVIDIA	0.10	3.39	2.96
SMR NuScale Power	N/A	6.23	6.23
TMDX TransMedics Group	1.61	9.86	9.17

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DAVE Dave	18.01%
NVDA NVIDIA	65.27%
SMR NuScale Power	78.37%
TMDX TransMedics Group	99.67%

Insider Ownership

Company	Insider Ownership
DAVE Dave	28.48%
NVDA NVIDIA	4.17%
SMR NuScale Power	1.27%
TMDX TransMedics Group	7.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DAVE Dave	250	13.34 million	9.54 million	Optionable
NVDA NVIDIA	36,000	24.40 billion	23.38 billion	Optionable
SMR NuScale Power	440	284.39 million	280.78 million	Optionable
TMDX TransMedics Group	210	34.09 million	31.70 million	Optionable

TMDX, NVDA, DAVE, and SMR Headlines

Recent News About These Companies

TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Blair William & Co. IL

August 7 at 4:15 AM | marketbeat.com

Why TransMedics (TMDX) is a Top Momentum Stock for the Long-Term

August 6 at 10:51 AM | zacks.com

TransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

August 6 at 2:06 AM | americanbankingnews.com

TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of "Moderate Buy" from Brokerages

August 6 at 2:04 AM | marketbeat.com

TransMedics Group (NASDAQ:TMDX) Trading 6.8% Higher Following Analyst Upgrade

August 6 at 2:13 AM | americanbankingnews.com

TransMedics Group (NASDAQ:TMDX) Stock Price Up 6.8% After Analyst Upgrade

August 5 at 11:10 AM | marketbeat.com

5,100 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Acquired by Allianz Asset Management GmbH

August 5 at 6:17 AM | marketbeat.com

TransMedics Group (NASDAQ:TMDX) Upgraded at Wall Street Zen

August 5 at 2:57 AM | americanbankingnews.com

TransMedics stock surges after FDA grants conditional approval for heart trial

August 4 at 2:35 PM | investing.com

TransMedics Stock Surges Following FDA Conditional Approval for Heart Trial

August 4 at 2:35 PM | msn.com

Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term

August 4 at 10:45 AM | zacks.com

TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

August 4 at 8:00 AM | prnewswire.com

TransMedics Group (NASDAQ:TMDX) Price Target Raised to $123.00

August 4 at 3:35 AM | americanbankingnews.com

XTX Topco Ltd Acquires Shares of 19,342 TransMedics Group, Inc. (NASDAQ:TMDX)

August 3, 2025 | marketbeat.com

TransMedics Group (NASDAQ:TMDX) Upgraded by Wall Street Zen to "Buy" Rating

August 3, 2025 | marketbeat.com

TransMedics Group, Inc. (TMDX): A Bull Case Theory

August 2, 2025 | insidermonkey.com

TransMedics Group, Inc. (TMDX): A Bull Case Theory

August 2, 2025 | finance.yahoo.com

TransMedics Group (NASDAQ:TMDX) Price Target Raised to $123.00 at Morgan Stanley

August 2, 2025 | marketbeat.com

TransMedics Group (NASDAQ:TMDX) Shares Gap Up After Earnings Beat

August 2, 2025 | americanbankingnews.com

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

August 1, 2025 | prnewswire.com

TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up

August 1, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

5 Stocks to Buy and Hold for the Rise of Physical AI
By Thomas Hughes | July 23, 2025
View 5 Stocks to Buy and Hold for the Rise of Physical AI
NVDA Greenlight: China H20 Sales Spark 50% Rally Potential
By Thomas Hughes | July 15, 2025
View NVDA Greenlight: China H20 Sales Spark 50% Rally Potential
AMD Just Triggered a Signal Traders Can’t Ignore
By Thomas Hughes | July 16, 2025
View AMD Just Triggered a Signal Traders Can’t Ignore
Top Stocks Powering the Fourth Industrial Revolution
By Thomas Hughes | July 24, 2025
View Top Stocks Powering the Fourth Industrial Revolution
AMD Outperforming NVIDIA: What’s Behind It and Can It Continue?
By Dan Schmidt | August 4, 2025
View AMD Outperforming NVIDIA: What’s Behind It and Can It Continue?

TMDX, NVDA, DAVE, and SMR Company Descriptions

Dave NASDAQ:DAVE

$191.39 -4.72 (-2.41%)

Closing price 04:00 PM Eastern

Extended Trading

$189.00 -2.39 (-1.25%)

As of 07:59 PM Eastern

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.

NVIDIA NASDAQ:NVDA

$180.77 +1.35 (+0.75%)

Closing price 04:00 PM Eastern

Extended Trading

$181.59 +0.82 (+0.45%)

As of 08:00 PM Eastern

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

NuScale Power NYSE:SMR

$44.79 -1.14 (-2.48%)

Closing price 04:00 PM Eastern

Extended Trading

$43.77 -1.02 (-2.27%)

As of 08:00 PM Eastern

NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs. The company was founded in 2007 and is headquartered in Portland, Oregon. NuScale Power Corporation operates as a subsidiary of Fluor Enterprises, Inc.

TransMedics Group NASDAQ:TMDX

$116.05 -2.75 (-2.31%)

Closing price 04:00 PM Eastern

Extended Trading

$116.02 -0.02 (-0.02%)

As of 07:48 PM Eastern

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time